PERSPECTA

News from every angle

← Back to headlines

Eli Lilly Benefits from GLP-1 Franchises Drug Growth

Eli Lilly (LLY) has seen gains driven by the strong performance and growth of its GLP-1 franchises drugs.

25 Mar, 14:21 — 25 Mar, 14:21
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual18d ago

Eli Lilly (LLY) Gained From Growth in its GLP-1 Franchises Drugs

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Truck Carrying Undeclared Fuel Seized at Tabaco Port, Philippines

just now

Philippines Affirms Sovereign Rights in Oil Exploration Agreements

just now

Philippines Assures Adherence to Laws in Joint Oil Exploration Talks

just now